What does Pharmaceutica do?

Pharmaceutica is a pharmacy in Lier. Private Limited, started on 1 January 1968, 1 establishment.

What is the address of Pharmaceutica?

The registered office of Pharmaceutica is located at Antwerpsestraat 149, 2500 Lier.

Is Pharmaceutica still active?

Yes. According to the CBE (30 October 2026) Pharmaceutica is active, legal situation “Normale toestand”, started on 1 January 1968.

Is Pharmaceutica registered on Peppol?

Yes, Pharmaceutica is registered on the Peppol network with ID 0208:0404041820.

What is the enterprise number of Pharmaceutica?

The enterprise number of Pharmaceutica is BE0404041820.

When was Pharmaceutica founded?

Pharmaceutica was founded on 1 January 1968.

Who are the directors of Pharmaceutica?

According to the 2025 annual accounts, the directors of Pharmaceutica are: Paul De Saedeleer.

Is Pharmaceutica a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1968; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pharmaceutica make in 2025?

Pharmaceutica posted a profit after taxes of € 22,515 in financial year 2025.

What is the revenue of Pharmaceutica?

As a small company, Pharmaceutica is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,007,210.

How much does an employee at Pharmaceutica earn?

The average wage cost per full-time employee at Pharmaceutica was € 71,100 in 2025: staff costs of € 795,835 for 11.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmaceutica have?

According to the 2025 annual accounts, Pharmaceutica has 11.2 full-time equivalents (FTE).

Does Pharmaceutica have a website?

Yes, Pharmaceutica has a website at apotheek-desaedeleer.be.

Pharmaceutica (Private Limited) - Lier - BE0404041820

Dossier Pharmaceutica, printed on 30 October 2026 from databakkes.be/en/0404041820/pharmaceutica. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmaceutica from Lier, company number BE0404041820, closed financial year 2025 with a result of € 22,515 after tax. For that financial year Pharmaceutica recorded a gross margin of € 1 million and equity of € 2.9 million. Compared with financial year 2024, the result moved from € 10,093 to € 22,515. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Healthy

€ 2.9 million

▼ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 22,515

▲ 123% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 447,954

▼ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 526,316 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

11.2

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 795,835

€ 71,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 109,894

▲ 40% vs 2024

Of which on lease € 44,799.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 648,419

▼ 19% vs 2024

€ 499,654 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 246,652

▲ 96% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 90,908

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 970,505 Gross margin 2022: € 970,505 First fiscal year in the series	€ 1,033,615 Gross margin 2023: € 1,033,615 ▲ 7% vs 2022 (€ 970,505) Favourable step	€ 1,003,653 Gross margin 2024: € 1,003,653 ▼ 3% vs 2023 (€ 1,033,615) Unfavourable step	€ 1,007,210 Gross margin 2025: € 1,007,210 Unchanged (€ 1,003,653) Favourable step
Profit after taxes	€ 549,756 Profit after taxes 2022: € 549,756 First fiscal year in the series	€ 156,013 Profit after taxes 2023: € 156,013 ▼ 72% vs 2022 (€ 549,756) Unfavourable step	€ 10,093 Profit after taxes 2024: € 10,093 ▼ 94% vs 2023 (€ 156,013) Unfavourable step	€ 22,515 Profit after taxes 2025: € 22,515 ▲ 123% vs 2024 (€ 10,093) Favourable step	▲ 123%
Equity	€ 3,948,081 Equity 2022: € 3,948,081 First fiscal year in the series	€ 3,356,314 Equity 2023: € 3,356,314 ▼ 15% vs 2022 (€ 3,948,081) Unfavourable step	€ 3,366,407 Equity 2024: € 3,366,407 Unchanged (€ 3,356,314) Favourable step	€ 2,857,433 Equity 2025: € 2,857,433 ▼ 15% vs 2024 (€ 3,366,407) Unfavourable step	▼ 15%
Total debts	€ 1,519,065 Total debts 2022: € 1,519,065 First fiscal year in the series	€ 1,167,659 Total debts 2023: € 1,167,659 ▼ 23% vs 2022 (€ 1,519,065) Favourable step	€ 1,063,466 Total debts 2024: € 1,063,466 ▼ 9% vs 2023 (€ 1,167,659) Favourable step	€ 986,263 Total debts 2025: € 986,263 ▼ 7% vs 2024 (€ 1,063,466) Favourable step	▼ 7%
Cash	€ 750,828 Cash 2022: € 750,828 First fiscal year in the series	€ 648,949 Cash 2023: € 648,949 ▼ 14% vs 2022 (€ 750,828) Unfavourable step	€ 487,958 Cash 2024: € 487,958 ▼ 25% vs 2023 (€ 648,949) Unfavourable step	€ 447,954 Cash 2025: € 447,954 ▼ 8% vs 2024 (€ 487,958) Unfavourable step	▼ 8%
Land & buildings	€ 685,291 Land & buildings 2022: € 685,291 First fiscal year in the series	€ 661,556 Land & buildings 2023: € 661,556 ▼ 3% vs 2022 (€ 685,291) Unchanged	€ 631,055 Land & buildings 2024: € 631,055 ▼ 5% vs 2023 (€ 661,556) Unchanged	€ 599,116 Land & buildings 2025: € 599,116 ▼ 5% vs 2024 (€ 631,055) Unchanged	▼ 5%
Retained profit	€ 3,929,489 Retained profit 2022: € 3,929,489 First fiscal year in the series	€ 3,337,722 Retained profit 2023: € 3,337,722 ▼ 15% vs 2022 (€ 3,929,489) Unfavourable step	€ 3,347,815 Retained profit 2024: € 3,347,815 Unchanged (€ 3,337,722) Favourable step	€ 2,838,841 Retained profit 2025: € 2,838,841 ▼ 15% vs 2024 (€ 3,347,815) Unfavourable step	▼ 15%
Dividend	€ 241,921 Dividend 2022: € 241,921 First fiscal year in the series	€ 747,780 Dividend 2023: € 747,780 ▲ 209% vs 2022 (€ 241,921) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 747,780) Unchanged	€ 526,316 Dividend 2025: € 526,316 Unchanged (€ 0) Unchanged
Bank debt	€ 1,070,801 Bank debt 2022: € 1,070,801 First fiscal year in the series	€ 954,811 Bank debt 2023: € 954,811 ▼ 11% vs 2022 (€ 1,070,801) Favourable step	€ 796,356 Bank debt 2024: € 796,356 ▼ 17% vs 2023 (€ 954,811) Favourable step	€ 648,419 Bank debt 2025: € 648,419 ▼ 19% vs 2024 (€ 796,356) Favourable step	▼ 19%
Balance sheet total	€ 5,467,146 Balance sheet total 2022: € 5,467,146 First fiscal year in the series	€ 4,523,973 Balance sheet total 2023: € 4,523,973 ▼ 17% vs 2022 (€ 5,467,146) Unchanged	€ 4,429,873 Balance sheet total 2024: € 4,429,873 ▼ 2% vs 2023 (€ 4,523,973) Unchanged	€ 3,843,696 Balance sheet total 2025: € 3,843,696 ▼ 13% vs 2024 (€ 4,429,873) Unchanged	▼ 13%
Employees (FTE)	12.1 Employees (FTE) 2022: 12.1 First fiscal year in the series	11.9 Employees (FTE) 2023: 11.9 ▼ 0.2 vs 2022 (12.1) Unchanged	11.2 Employees (FTE) 2024: 11.2 ▼ 0.7 vs 2023 (11.9) Unchanged	11.2 Employees (FTE) 2025: 11.2 Unchanged (11.2) Unchanged

Key figures of Pharmaceutica, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmaceutica?

What happened at Pharmaceutica in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 22,515 (▲ 123% vs 2024). Source: NBB ↗
Jan 1, 1968 Start of the company according to the CBE. KBO
May 1, 1962 New establishment in Lier. KBO

In short

From € 549,756 profit in 2022 to € 22,515 profit in 2025.

Paid € 90,583 in corporate taxes since 2022.

Best year ever: 2022, with € 549,756 profit.

On average € 89,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Paul De Saedeleer

Pharmaceutica

Nutrined 100%

Behind Pharmaceutica is Paul De Saedeleer. It owns 100% of Nutrined itself.

Directors

According to the 2025 annual accounts

Paul De Saedeleer

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Antwerpsestraat 149

2500 Lier

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

RESEARCHED SUPPLEMENTS

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheek-desaedeleer.be

Technologies

AMPAdobe FontsAlpine.jsCookie ConsentGoogle FontsGoogle TranslateNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Hosting & Email

Email provider

Outlook.com (free)

Hosting

UPCLOUD, FI

Website info

HTTPS Ja

Indexable pages 53,283

Languages NL

Features

Webshop Newsletter

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0404.041.820

VAT number

BE 0404.041.820

Registered office

Antwerpsestraat 149, 2500 Lier

Names & denominations

Pharmaceutica

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 January 1968

Peppol

Active · Active since 25 Aug 2025

Contact

apotheek-desaedeleer.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmaceutica

Financials

What happened to Pharmaceutica?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions